» Articles » PMID: 28072738

Expression Quantitative Trait Loci for PI3K/AKT Pathway

Overview
Specialty General Medicine
Date 2017 Jan 11
PMID 28072738
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A genome-wide association study (GWAS) was conducted to identify expression quantitative trait loci (eQTLs) for the genes involved in phosphatidylinositol-3-kinase/v-akt murine thymoma viral oncogene homolog (PI3K/AKT) pathway.Data on mRNA expression of 341 genes in lymphoblastoid cell lines of 373 Europeans recruited by the 1000 Genomes Project using Illumina HiSeq2000 were utilized. We used their genotypes at 5,941,815 nucleotide variants obtained by Genome Analyzer II and SOLiD.The association analysis revealed 4166 nucleotide variants associated with expression of 85 genes (P < 5 × 10). A total of 73 eQTLs were identified as association signals for the expression of multiple genes. They included 9 eQTLs for both of the genes encoding collagen type I alpha 1 (COL1A1) and integrin alpha 11 (ITGA11), which synthesize a major complex of plasma membrane. They also included eQTLs for type IV collagen molecules; 13 eQTLs for both collagen type IV alpha 1 (COL4A1) and collagen type IV alpha 2 (COL4A2) and 18 eQTLs for both collagen type IV alpha 5 (COL4A5) and collagen type IV alpha 6 (COL4A6). Some genes expressed by the eQTLs might induce expression of the genes encoding type IV collagen. One eQTL (rs16871986) was located in the promoter of palladin (PALLD) gene which might synthesize collagen by activating fibroblasts through the PI3K/AKT pathway. Another eQTL (rs34845474) was located in an enhancer of cadherin related family member 3 (CDHR3) gene which can mediate cell adhesion.This study showed a profile of eQTLs for the genes involved in the PI3K/AKT pathway using a healthy population, revealing 73 eQTLs associated with expression of multiple genes. They might be candidates of common variants in predicting genetic susceptibility to cancer and in targeting cancer therapy. Further studies are required to examine their underlying mechanisms for regulating expression of the genes.

Citing Articles

The role of PI3K signaling pathway in Alzheimer's disease.

Pan J, Yao Q, Wang Y, Chang S, Li C, Wu Y Front Aging Neurosci. 2024; 16:1459025.

PMID: 39399315 PMC: 11466886. DOI: 10.3389/fnagi.2024.1459025.


and oxaloacetate in nucleus pulposus stromal cell somatic reprogramming and survival.

Lufkin L, Samanta A, Baker D, Lufkin S, Schulze J, Ellis B Front Mol Biosci. 2022; 9:1009402.

PMID: 36406265 PMC: 9671658. DOI: 10.3389/fmolb.2022.1009402.


Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers.

Bruno R, Poma A, Ali G, Distefano C, Proietti A, Chella A Diagnostics (Basel). 2022; 12(3).

PMID: 35328227 PMC: 8947498. DOI: 10.3390/diagnostics12030674.


Identification of potential core genes in gastric cancer using bioinformatics analysis.

Shao C, Wang R, Kong D, Gao Q, Xu C J Gastrointest Oncol. 2021; 12(5):2109-2122.

PMID: 34790378 PMC: 8576244. DOI: 10.21037/jgo-21-628.


Transcriptome sequencing reveals genes involved in cadmium-triggered oxidative stress in the chicken heart.

Yu C, Qiu M, Zhang Z, Song X, Du H, Peng H Poult Sci. 2021; 100(3):100932.

PMID: 33652545 PMC: 7936198. DOI: 10.1016/j.psj.2020.12.029.


References
1.
Goicoechea S, Arneman D, Otey C . The role of palladin in actin organization and cell motility. Eur J Cell Biol. 2008; 87(8-9):517-25. PMC: 2597190. DOI: 10.1016/j.ejcb.2008.01.010. View

2.
Abecasis G, Auton A, Brooks L, DePristo M, Durbin R, Handsaker R . An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56-65. PMC: 3498066. DOI: 10.1038/nature11632. View

3.
Dienstmann R, Rodon J, Serra V, Tabernero J . Picking the point of inhibition: a comparative review of PI3K/AKT/mTOR pathway inhibitors. Mol Cancer Ther. 2014; 13(5):1021-31. DOI: 10.1158/1535-7163.MCT-13-0639. View

4.
Hennessy B, Smith D, Ram P, Lu Y, Mills G . Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005; 4(12):988-1004. DOI: 10.1038/nrd1902. View

5.
Hildebrandt M, Yang H, Hung M, Izzo J, Huang M, Lin J . Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol. 2009; 27(6):857-71. PMC: 2738430. DOI: 10.1200/JCO.2008.17.6297. View